APA (7th ed.) Citation

H, M., K, M., T, S., A, M., K, K., M, T., . . . A, K. (2026). Impact of pre-existing interstitial lung abnormalities on pneumonitis risk and survival in chemo-naive patients with non-small-cell lung cancer receiving pembrolizumab plus chemotherapy. Respiratory medicine, 257, 108852. https://doi.org/10.1016/j.rmed.2026.108852

Chicago Style (17th ed.) Citation

H, Machiyama, et al. "Impact of Pre-existing Interstitial Lung Abnormalities on Pneumonitis Risk and Survival in Chemo-naive Patients with Non-small-cell Lung Cancer Receiving Pembrolizumab Plus Chemotherapy." Respiratory Medicine 257 (2026): 108852. https://doi.org/10.1016/j.rmed.2026.108852.

MLA (9th ed.) Citation

H, Machiyama, et al. "Impact of Pre-existing Interstitial Lung Abnormalities on Pneumonitis Risk and Survival in Chemo-naive Patients with Non-small-cell Lung Cancer Receiving Pembrolizumab Plus Chemotherapy." Respiratory Medicine, vol. 257, 2026, p. 108852, https://doi.org/10.1016/j.rmed.2026.108852.